ADARx Pharmaceuticals, Inc. (ADRX)

ADARx Pharmaceuticals will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

ADARx Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-0.03	-0.04	-0.03
Debt / EBITDA Ratio	-0.07	-0.09	-0.08
Debt / FCF Ratio	-0.08	0.03	-0.09
Net Debt / Equity Ratio	1.67	2.33	1.57
Net Debt / EBITDA Ratio	4.13	5.60	3.82
Net Debt / FCF Ratio	4.66	-1.82	4.39
Quick Ratio	12.56	15.75	24.56
Return on Equity (ROE)	35.00%	36.14%	33.80%
Return on Assets (ROA)	-	-14.40%	-19.86%
Return on Invested Capital (ROIC)	-	-25.19%	-25.94%
Return on Capital Employed (ROCE)	307.31%	-18.18%	-25.72%